Drug Discovery & Development | FDA Investigating Heart Failure Risks with Saxagliptin Drug Discovery & Development The U.S. Food and Drug Administration (FDA) has requested clinical trial data from the manufacturer of saxagliptin, which is co-developed by AstraZeneca and Bristol-Myers Squibb Co., to investigate a possible association between use of the type 2 ... |
